Mikhail S Chesnokov

4PUBLICATIONS
7CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 22, 2023
Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance.

I Khan, A Kaempf, S Raghuwanshi

|Nov 11, 2022
Optimized Transcriptional Signature for Evaluation of MEK/ERK Pathway Baseline Activity and Long-Term Modulations in Ovarian Cancer.

Mikhail S Chesnokov, Anil Yadav, Ilana Chefetz

|Jul 15, 2021
Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells.

Mikhail S Chesnokov, Marianna Halasi, Soheila Borhani

|Jun 12, 2018
Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinoma.

Mikhail S Chesnokov, Polina A Khesina, Darya A Shavochkina

Pageof 1

Frequent Collaborators

2 joint publications

Andrei L Gartel

1 joint publications

I Khan

1 joint publications

S Raghuwanshi

1 joint publications

J W Tyner